MoleculeMind releases MMDesign, claims over 90% target hit rate

超越国际顶尖模型！分子之心推MMDesign，靶点命中率狂飙至90%

MoleculeMind released MMDesign, an AI platform for de novo biologics design. In tests across 12 therapeutic targets, it validated specific binding on 11 targets, sending only 14 to 50 molecules per target into wet-lab assays and reporting a target success rate above 90%.

Why it matters: HKR-H/K/R all pass: MMDesign has concrete wet-lab numbers for de novo biologic design. The claim is vertical and partly promotional, so it stays in the 72–77 featured band rather than a broader must-write item.